The REFINE Project meets ResearchGate
Join the REFINE Project Community on ResearchGate and participate to the discussions
JOIN US REFINEasksyou

Ontology

In recent years, much effort has been undertaken to develop controlled vocabularies and scientific ontologies in biomedical fields.

Array
SCROLL DOWN

Ontology

Terminology standardisation and data handling are both included as informatics components, which are essential to nanotechnology data-sharing and interdisciplinary communication. They enable easier data and protocol storage, information retrieval and modelling of data output. Source: JRC Scientific and Policy Reports, Towards a review of the EC Recommendation for a definition of the term “nanomaterial” Part 1: Compilation of information concerning the experience with the definition

Nanomedicine

Nanomedicine is defined as the application of nanotechnology in view of making a medical diagnosis or treating or preventing diseases. It exploits the improved and often novel physical, chemical and biological properties of materials at nanometre scale.

Source: European Union

Nanomedicine

Nanomedicine, the application of nanotechnology to human healthcare, offers numerous potential pathways to improving medical diagnosis and therapy and even to regenerate tissues and organs. It can provide personalised yet more affordable healthcare while at the same time offering an improved quality of life for everyone.

Source: European Medicines Agency

Nanomedicines

Nanomedicines: The European Medicines Agency has established a working definition of nanomedicines defined as purposely designed systems for clinical applications [with] at least one component at nano-scale size [and] resulting in definable specific properties and characteristics. [Nanomedicines] are related to the specific technology application and characteristics for the intended use (route of admin, dose), associated with the expected clinical advantages of the nano-engineering (e.g. preferential organ/tissue distribution) and needs to meet definition as a medicinal product according to European legislation.

Source: European Union

Nanomedicines

Other terms used in EMA’s publications are: “medicinal products containing nanoparticles”, “nanomedicinal products” or “nanotechnology-based medicinal products”

Source: European Medicines Agency

Nanotechnology

Nanotechnology is defined as the production and application of structures, devices and systems by controlling the shape and size of materials at nanometre scale. The nanometre scale ranges from the atomic level at around .2 nm (2 Å) up to around 100 nm.

Source: European Medicines Agency

Nanotechnology

Nanotechnology is the use of tiny structures – less than 1,000 nanometres across – that are designed to have specific properties. Nanotechnology is an emerging field in science that is used in a wide range of applications, from consumer goods to health products.

Source European Union

LinkedIn